Xometry (NASDAQ: XMTR) director eyes $432,925 stock sale

Rhea-AI Filing Summary

Xometry, Inc. (XMTR) has a planned secondary sale of shares by a director. Emily Rollins, a director of the company, has filed to potentially sell 5,000 shares of Class A common stock under Rule 144 through UBS Financial Services Inc. The shares are to be issued via exercise of stock options for cash and then may be sold on or after 08/19/2026 on NASDAQ.

Key Figures

Shares to be sold: 5,000 shares Aggregate market value: $432,925.00 Planned sale date: 08/19/2026

3 metrics

Shares to be sold 5,000 shares Class A Common stock potentially to be sold under Rule 144

Aggregate market value $432,925.00 Reported aggregate market value for the 5,000 shares

Planned sale date 08/19/2026 Date associated with the potential Rule 144 sale and option exercise

Key Terms

Rule 144, Exercise of stock options, attorney-in-fact

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Exercise of stock options financial

"Class A Common | 08/19/2026 | Exercise of stock options | Issuer"

attorney-in-fact regulatory

"UBS Financial Services Inc, as attorney-in-fact for Emily Rollins"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

What does the Form 144 filing for XMTR disclose about Emily Rollins?

The filing shows that director Emily Rollins plans a potential Rule 144 sale of 5,000 shares of Xometry Class A common stock, with the shares coming from the exercise of stock options for cash on or after 08/19/2026.

How many XMTR shares are covered by this Form 144 notice?

The notice covers a potential sale of 5,000 shares of Xometry, Inc. Class A common stock. These shares are expected to be acquired through the exercise of stock options and may then be sold under Rule 144 conditions.

What is the reported market value of the XMTR shares in this Form 144?

The Form 144 lists an aggregate market value of $432,925.00 for the 5,000 XMTR shares. This reflects the approximate value at the time of the notice and is part of the required Rule 144 disclosure information.

When can the XMTR shares in this Form 144 be sold?

The shares may be sold on or after 08/19/2026, the date listed in the Form 144. The transaction involves the exercise of stock options for cash followed by a potential sale of the resulting shares under Rule 144.

Who is handling the potential sale of XMTR shares for Emily Rollins?

The potential sale is being handled by UBS Financial Services Inc. as broker, acting as attorney-in-fact for Emily Rollins. UBS is listed as the brokerage firm through which the 5,000 shares of Xometry Class A common stock may be sold.

What is the source of the XMTR shares to be sold under this Form 144?

The shares are to be obtained via the exercise of stock options in exchange for cash. After exercising, up to 5,000 shares of Xometry Class A common stock may be sold in compliance with Rule 144 requirements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/19/2026 - 04:13 PM Accepted by SEC EDGAR 08/19/2026 - 04:13 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001847014
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Xometry, Inc.
SEC File Number	001-40546
Address of Issuer	6116 EXECUTIVE BOULEVARD, SUITE 800 NORTH BETHESDA MARYLAND 20852
Phone	240-335-7914
Name of Person for Whose Account the Securities are To Be Sold	Rollins Emily
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common	UBS Financial Services, Inc. 11 Madison Ave 4th Floor New York NY 10010	5000	432925.00	55848262	08/19/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common	08/19/2026	Exercise of stock options	Issuer			5000	08/19/2026	CASH

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/19/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/20/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for Emily Rollins
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)